Europe Cannabis Market to Witness Rapid Growth through 2024
Rising adoption of cannabis
as a medical product and increasing legalisation of cannabis are driving Europe
Cannabis market
According to
TechSci Research report, “Europe
Cannabis Market By Product Type, By Compound, By Application, By Company, Competition,
Forecast & Opportunities, 2024”, the Europe cannabis market
is expected to grow rapidly during the forecast period on the account of its
rising applications in treatment of pain, anxiety, sleep disorders, and other
medical conditions such as fibrotic problems and neuropathic pain. Over €500
million has been invested in the cannabis industry until 2018, and six
countries have announced new legislations regarding the growth, sale or
consumption of cannabis. Countries including Germany, Italy, Netherlands are considered
as the Cannabis industry leaders that are focusing more on expanding existing
medical programs, thus aiding the growth of Europe cannabis market.
Browse XX market data Tables and XX Figures spread
through 80 Pages and an
in-depth TOC on " Europe Cannabis Market"
https://www.techsciresearch.com/report/europe-cannabis-market/4260.html
The Europe cannabis market is segmented based on product type, compound,
application, region and company. Based on application, the market can be bifurcated
into Medical and Recreational. The recreational segment is anticipated to
witness higher traction over the next five years. Despite recreational cannabis
having a low presence, its consumption and demand remain almost equal when
compared to medicinal cannabis. Additionally, due to legalization in various
countries, the demand for recreational cannabis is projected to surpass the
demand for medical cannabis by 2024. In terms of Compound, the cannabis market
is segmented into THC-Dominant, CBD-Dominant, and Balanced THC & CBD. Out
of these, THC-dominant is projected to be the fastest-growing segment in the region’s
cannabis market during 2019-2024. The dominance of this segment is majorly attributed to
the fact that THC is the psychoactive substance in cannabis products and is
responsible for head high feeling. Even though high THC content is better known
for its mind-altering euphoria, it has important medical benefits and is
considered effective in relieving nausea, appetite loss, and insomnia.
Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=4260
Customers can also request for 10% free customization
on this report.
Bedrocan Cannabis
Corp., Aurora Cannabis, Canopy Growth, Aphria Inc., Demecan GmBH, Tilray Inc.
and Cronos Group, among others are some of the leading players operating in Europe
cannabis market. “With a population that is about double than that of the
United States and Canada combined, the Europe cannabis market is ripe, and the
industry has grown more in the last year than over the last six years combined.
Over the next five years, Europe is set to become the world’s largest legal
cannabis market. The cannabis market would be among the fastest growing markets
during the forecast period owing to rising support of the governments for the
application of cannabis in medical as well as in recreational treatment. The
number of people using marijuana is projected to increase owing to less
limitations, lower prices, and ease of access that is expected to spur the
growth of the market through 2024.” said Mr. Karan Chechi, Research Director
with TechSci Research, a research based global management consulting firm.
“Europe Cannabis Market By Product Type, By Compound,
By Application, Competition, Forecast & Opportunities, 2024” has evaluated the future growth potential of Europe
cannabis market and provides statistics & information on market size,
structure and future market growth. The report intends to provide cutting-edge
market intelligence and help decision makers take sound investment decisions. Besides,
the report also identifies and analyzes the emerging trends along with
essential drivers, challenges and opportunities in Europe cannabis market.
Contact
Mr. Ken Mathews
708 Third Avenue,
Manhattan, NY,
New York – 10017
Tel: +1-646-360-1656
Email: [email protected]